Titan Medical Inc. Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Share Capital - Additional Information (Detail)

Share Capital - Additional Information (Detail)									1 Months Ended				3 Months Ended	12 Months Ended
Share Capital - Additional Information (Detail)	Dec. 23, 2019 USD ($) shares	Mar. 21, 2019 USD ($) $ / shares shares	Aug. 10, 2018 USD ($) $ / shares shares	Jun. 19, 2018 shares	May 10, 2018 USD ($) $ / shares shares	May 10, 2018 USD ($) $ / shares	Apr. 10, 2018 USD ($) shares	Apr. 10, 2018 USD ($) $ / shares	Aug. 29, 2019 USD ($) $ / shares shares	May 29, 2019 USD ($)	May 29, 2019 CAD ($) $ / shares	May 28, 2019	Mar. 31, 2019 USD ($) shares	Dec. 31, 2019 USD ($) $ / shares shares	Dec. 31, 2019 CAD ($) shares	Dec. 31, 2018 USD ($) shares	Dec. 31, 2019 CAD ($) $ / shares shares	May 29, 2019 $ / shares	Dec. 31, 2018 $ / shares shares	Dec. 31, 2018 $ / shares shares	Dec. 31, 2017 $ / shares
Disclosure of classes of share capital [line items]
Number of shares outstanding \| shares				419,888,250										39,907,681			39,907,681		21,675,849	21,675,849
Number of shares outstanding, adjusted \| shares				13,996,275
Reverse stock split ratio				30
Effective date of reverse stock split				Jun. 20, 2018
Offering price per share \| $ / shares		$ 3.40
Cash commission														$ 1,136,146		$ 785,128
Amount allocated to common shares														$ 7,002,043		$ 59,998
Warrant exercised \| shares														1,018,506			1,018,506		6,500	6,500
Number of common shares available for issue under stock option plan \| shares														5,986,152	5,986,152	1,241,803
Weighted average exercise price of options exercisable														$ 3.02			$ 7.35
Stock based compensation														1,651,119		$ 1,505,625
Stock based compensation Liability														183,437			$ 240,070
Stock issuance costs														$ 2,090,124		$ 1,297,668
Canadian Dollar [Member]
Disclosure of classes of share capital [line items]
Weighted average exercise price of options outstanding \| $ / shares																	$ 5.89		$ 18.20		$ 21.30
US Dollar [Member]
Disclosure of classes of share capital [line items]
Weighted average exercise price of options outstanding \| $ / shares														$ 2.65						$ 1.55
Warrants expiring between March 16, 2019 and August 10, 2020 [member]
Disclosure of classes of share capital [line items]
Broker Warrants issued and outstanding \| shares																			786,183	786,183
Warrants expiring between April 10, 2020 and March 21, 2021 Member [Member]
Disclosure of classes of share capital [line items]
Broker Warrants issued and outstanding \| shares														1,219,276			1,219,276
Before Amendment [Member]
Disclosure of classes of share capital [line items]
Percentage of common shares reserved for issuance												10.00%
After Amendment [Member]
Disclosure of classes of share capital [line items]
Percentage of common shares reserved for issuance										15.00%	15.00%
Amendment [Member]
Disclosure of classes of share capital [line items]
Stock based compensation														$ 292,184	$ 382,390
Exercise prices/option \| (per share)											$ 4.54							$ 3.40
Incremental stock based compensation										$ 475,622	$ 622,460
Over Allotment Option 1 [member]
Disclosure of classes of share capital [line items]
Warrant exercised \| shares													1,018,506
Proceeds from warrant exercised													$ 3,259,219
Amount reclassed from warrant liability to common stock													$ 3,742,824
Aspire Agreement [Member]
Disclosure of classes of share capital [line items]
Gross proceeds from offerings														3,000,000
Cash commission														$ 417,113
Bloom Burton Securities Inc [member]
Disclosure of classes of share capital [line items]
Sale of offering units \| shares		8,455,882	7,679,574				1,126,664
Offering price per share \| (per share)		$ 3.40	$ 2.50			$ 9.00		$ 9.00
Gross proceeds from offerings		$ 28,750,000	$ 19,198,935				$ 8,035,941
Cash commission		2,012,500	1,343,925		$ 76,988		562,516
Net proceeds from offering		$ 25,426,744	$ 17,464,711				7,211,320
Exercise price per share \| (per share)		$ 4.00	$ 3.20			$ 10.50		$ 10.50
Fair value of warrants		$ 15,897,059	$ 6,297,251		658,387	$ 658,387	4,553,700	$ 4,553,700
Amount allocated to common shares		$ 12,852,941	$ 12,901,684		$ 531,469		$ 3,482,241
Warrants expiration period		Mar. 21, 2024	Aug. 10, 2023		Apr. 10, 2023		Apr. 10, 2023
Sale of offering additional units \| shares					168,888
Gross proceeds from additional offerings					$ 1,189,856
Net proceeds from additional offering					$ 1,100,238
Bloom Burton Securities Inc [member] \| Over Allotment Option 1 [member]
Disclosure of classes of share capital [line items]
Fair value of warrants		$ 864,190
Warrants expiration period		Mar. 21, 2021	Aug. 10, 2020		Apr. 10, 2020		Apr. 10, 2020
Broker Warrants to purchase of common stock \| shares		591,911	537,570		10,928		78,867
Common stock price per share \| (per share)		$ 3.40	$ 2.50		$ 9.00			$ 9.00
Aspire Capital Fund LLC [Member] \| Aspire Agreement [Member]
Disclosure of classes of share capital [line items]
Shares issued \| shares	973,000								1,777,325					7,784,444			7,784,444
Offering price per share \| $ / shares									$ 1.6879
Gross proceeds from offerings									$ 3,000,000
Capital Issued Commitments	$ 35,000,000								$ 35,000,000
Percentage Of Shares Outstanding									5.30%
Common stock shares issued value	423,440													$ 5,304,531
Stock issuance costs	$ 35,122
Aspire Capital Fund LLC [Member] \| Aspire Agreement [Member] \| Additional Commitment [Member]
Disclosure of classes of share capital [line items]
Shares issued \| shares									639,837
Percentage Of Shares Outstanding									1.90%
Northland Securities Inc [Member] \| Aspire Agreement [Member]
Disclosure of classes of share capital [line items]
Cash commission									$ 160,000